Mark S. Talamonti

8.0k citations
96 papers · 6.0k · 3 hit papers · h-index 35

Impact in

  • Oncology top 0.5%
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Research Studies
    • Gastrointestinal Tumor Research and Treatment

Papers in

    • Pancreatic and Hepatic Oncology Research 39
    • Pancreatitis Pathology and Treatment 13
    • Cholangiocarcinoma and Gallbladder Cancer Studies 11

Mark S. Talamonti

92 papers receiving 5.9k citations

Mark S. Talamonti's Hit Papers

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement 2009 · 641 citations
6410+6+12Years since publication200400600

Peers

Mark S. Talamonti
Comparison fields: 5 of 111
  • Oncology 3.8k
  • Gastroenterology 608
  • Cancer Research 939
  • Surgery 2.3k
  • Pulmonary and Respiratory Medicine 1.6k
Replace Enrique Grande with:
Enrique Grande Spain
Thomas Aparicio France
Scott A. Hundahl United States
Maria Di Bartolomeo Italy
Peter C. Enzinger United States
Irene Floriani Italy
Taylor A. Sohn United States
Young Suk Park South Korea
Peter Harper United Kingdom
Romain Coriat France
Mark S. Talamonti relative to Enrique Grande Spain Enrique Grande's profile →
Citations per field
00.5×9.1×
Enrique Grande · 1×
Citations per year

Countries citing papers authored by Mark S. Talamonti

Since Specialization
Citations

This map shows the geographic impact of Mark S. Talamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Talamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Talamonti more than expected).

Fields of papers citing papers by Mark S. Talamonti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Talamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Talamonti. The network helps show where Mark S. Talamonti may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark S. Talamonti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Talamonti Line = papers co-authored together Mark S. Talamonti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Hit paper breakdown →
2009641
2
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
Hit paper breakdown →
2007487
3
Small Bowel Cancer in the United States
Hit paper breakdown →
2008442
4 1993352
5 2007344
6
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs . observation on survival in patients with resected periampullary adenocarcinoma
2013284
7 2008278
8 2011245
9 2010176
10 2006174
11 2008132
12 2008126
13 2007124
14 2008122
15 2010104
16 2000102
17 199698
18 200997
19 201396
20 199394

About Mark S. Talamonti

Mark S. Talamonti is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Cancer Research, having authored 96 papers that have together received 6.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (39 papers), Neuroendocrine Tumor Research Advances (15 papers), Pancreatitis Pathology and Treatment (13 papers), Cancer Genomics and Diagnostics (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Gastric Cancer Management and Outcomes (9 papers), Gallbladder and Bile Duct Disorders (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). The work is most often cited by research in Oncology (3.8k citations), Gastroenterology (608 citations), Cancer Research (939 citations), Surgery (2.3k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Mark S. Talamonti has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Karl Y. Bilimoria, David J. Bentrem, Clifford Y. Ko, Andrew K. Stewart, David P. Winchester, Robert Marsh, Jeffrey D. Wayne, Gary E. Gallick, Kenneth J. Chang and Elliot K. Fishman. Their work appears in journals such as Surgery, Journal of Surgical Oncology, Gastroenterology, Annals of Surgical Oncology and HPB.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact